XOMA ROYALTY

Financial services, namely, financing related to intellectual property portfolios; Financial services, namely, financing of pharmaceutical, drug, and medical device development; Financial services, namely, providing capital to others by monetizing royalty streams and acquiring revenue interests relating to the sale of products; Financial services, namely, funding through debt-like structures, the development and commercialization of products; Financial services, namely, providing non-dilutive capital to counterparties, including through the purchase of revenue interests and the use of debt-like structures; Equity capital investment

pharmaceutical research and development

licensing of intellectual property; licensing of pharmaceutical, biopharmaceutical, medicine, and chemical products and technology